La crescente attenzione allo sviluppo di prodotti terapeutici proteici, le continue innovazioni nei farmaci a base di proteine ricombinanti e i crescenti farmaci a base di anticorpi hanno portato a un aumento della ricerca sui farmaci a base di proteine ricombinanti. ingegneria delle proteine. Le proteine e i peptidi terapeutici sono stati identificati anche come un grande potenziale per il trattamento di varie malattie come il cancro, le malattie neurodegenerative e altre. Tuttavia, l'instabilità fisico-chimica delle proteine e i problemi di immunogenicità potrebbero frenare il mercato globale delle terapie proteiche nel periodo di previsione.
L'analisi del mercato globale delle terapie proteiche fino al 2031 è uno studio specializzato e approfondito di l’industria delle biotecnologie con un focus sull’andamento del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato globale con una segmentazione dettagliata del mercato per prodotto, applicazione, utente finale e area geografica. Si prevede che il mercato globale Proteine Terapeutiche assisterà a una crescita elevata durante il periodo di previsione. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato Proteine terapeutiche e offre tendenze e opportunità chiave nel mercato.
Il mercato globale Proteine terapeutiche è segmentato sulla base del prodotto, dell’applicazione, della fine utente. In base al prodotto, il mercato è segmentato in anticorpi monoclonali, insulina, proteina di fusione, eritropoietina, interferone, ormone della crescita umano e ormone follicolo-stimolante. Il mercato delle terapie proteiche per applicazione è classificato in disturbi metabolici, disturbi immunologici, disturbi ematologici, cancro, disturbi ormonali, disturbi genetici e altri. In base all'utente finale, il mercato delle terapie proteiche è classificato in aziende farmaceutiche, fornitori di servizi sanitari, organizzazioni di ricerca e aziende farmaceutiche. istituti di ricerca accademica.
Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del prodotto, dell’applicazione e dell’utente finale basati sul mercato globale delle proteine terapeutiche. Fornisce inoltre le dimensioni del mercato e le previsioni fino al 2031 per il mercato complessivo rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud & America Centrale. Il mercato delle proteine terapeutiche in ciascuna regione è successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l'analisi e le previsioni di 13 paesi a livello globale insieme alle tendenze attuali e alle opportunità prevalenti nella regione.
Il Nord America ha detenuto la quota dominante nel mercato delle terapie proteiche nel 2021. La quota maggiore è attribuita ai progressi tecnologici , politiche di rimborso favorevoli, lo sviluppo di nuovi prodotti e il miglioramento del tenore di vita hanno portato ad un aumento dell'aspettativa di vita, contribuendo all'aumento della popolazione geriatrica. Questi fattori stanno stimolando la crescita delle terapie proteiche in questa regione.
Si prevede che la regione Asia-Pacifico mostrerà il CAGR più elevato durante il periodo di previsione a causa dell'elevata prevalenza di malattie croniche come il diabete. Inoltre, anche la crescente industria del turismo medico nella regione dell’Asia del Pacifico è un fattore importante che, si prevede, spingerà la domanda del mercato per il mercato delle terapie proteiche durante il periodo di previsione. Inoltre, si prevede che fattori come la crescente domanda di opzioni terapeutiche avanzate, le economie emergenti come Cina, India e Giappone e l’aumento del reddito pro capite creeranno strade di crescita per gli operatori del mercato dell’Asia Pacifico nel periodo di previsione.
Il rapporto analizza i fattori che influenzano il mercato delle proteine terapeutiche sia dal lato della domanda che dell’offerta e valuta ulteriormente le dinamiche di mercato che influenzano il mercato durante il periodo di previsione, vale a dire fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud & America Centrale dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato delle proteine terapeutiche in queste regioni.
Il rapporto include anche i profili delle principali società delle proteine terapeutiche insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni e sviluppi chiave negli ultimi cinque anni. Alcuni dei principali attori che operano nel mercato Protein Therapeutics includono Novo Nordisk A/S, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Amgen Inc., AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Kyowa Hakko Kirin Co., Ltd., Pfizer Inc. e F. Hoffmann-La Roche Ltd tra gli altri.
.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Key companies in this market are - Novo Nordisk A/S, Janssen Global Services LLC, Johnson & Johnson Services Inc, Amgen Inc, AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Kyowa Hakko Kirin Co Ltd, Pfizer Inc
The Protein Therapeutics Market is expected to witness a shift towards personalised medicine with enormous focus on tailored therapy. Innovative therapeutic proteins, better drug design and advancement in protein engineering would deliver enhanced efficacy, addressing specific patient need and expanding market applications.
The market is expected to register a CAGR of 6.5% during 2023-2031
Fueling the growth of the Protein Therapeutics Market is the rising incidence of chronic diseases, and the growing need for biologic therapeutics. Also, the rising demand for protein-based therapies is due to the rising acceptance of biological therapies, global efforts to cure chronic diseases, and scientific advancements in protein engineering and manufacturing.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For